Spread Analysis of COVID-19 Outbreak in France by Self-assessment Web-application
NCT ID: NCT04670003
Last Updated: 2021-04-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
4975 participants
OBSERVATIONAL
2021-01-02
2021-03-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Viral contamination is airborne and fecal A first epidemic wave crossed France in March / April 2020 then a second in October / November with a source of contamination which began in mid-August 2020. The sources of propagation are not well known (what places, what times, what contacts…? ) In the context of the health crisis linked to the coronavirus, knowledge of the sources of propagation of this 2nd wave is an important issue to guide end of lockdown and second lockdown policies.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Interpretation of Health News Items Reporting Results of Randomized Controlled Trials With or Without Spin by French-speaking Population
NCT03095950
Interpretation of Health News Items Reporting Results of Pre-clinical Studies With or Without Spin By French-speaking Population
NCT03071627
Interpretation of Health News Items Reporting Results of Randomized Controlled Trials With or Without Spin by English-speaking Population
NCT03095911
Environmental Exposures and Sudden Unexpected Infant Death
NCT06708793
Improving Disease Prevention Strategies by Integrating Socio-spatial Characterization of Human Mobility
NCT06599970
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
users
users of web-application
users
Data of users of the web-application
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
users
Data of users of the web-application
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* not having objected to the use of their data
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kelindi
INDUSTRY
Weprom
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Fabrice DENIS, MD
Role: STUDY_DIRECTOR
Institut Interrégional de Cancerologie et Kelindi
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institut Interrégional de Cancérologie
Le Mans, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Denis F, Septans AL, Le Goff F, Jeanneau S, Lescure FX. Analysis of COVID-19 Transmission Sources in France by Self-Assessment Before and After the Partial Lockdown: Observational Study. J Med Internet Res. 2021 May 4;23(5):e26932. doi: 10.2196/26932.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
WP-2020-05
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.